Hetero Labs Limited — Simvastatin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Simvastatin · $7.1M export value · DGFT Verified
Hetero Labs Limited is the #6 Indian exporter of Simvastatin with $7.1M in export value and 144 verified shipments. Hetero Labs Limited holds a 5.6% market share in Simvastatin exports across 3 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.
Hetero Labs Limited — Simvastatin Export Profile: Buyers & Destinations
Where Does Hetero Labs Limited Export Simvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.7M | 111 | 85.6% |
| CANADA | $620.7K | 31 | 14.3% |
| TURKMENISTAN | $5.9K | 2 | 0.1% |
Hetero Labs Limited exports Simvastatin to 3 countries. The largest destination is UNITED STATES accounting for 85.6% of Hetero Labs Limited's Simvastatin shipments, followed by CANADA (14.3%) and TURKMENISTAN (0.1%). These destinations reflect Hetero Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Simvastatin from Hetero Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | UNITED STATES | $3.2M | 88 |
| MINT PHARMACEUTICALS INC. | CANADA | $268.7K | 10 |
| TO THE ORDER OF.... | UNITED STATES | $119.6K | 3 |
| M S TO THE ORDER OF CURASCRIPT SD SPECIALTY | UNITED STATES | $110.0K | 5 |
| PRIORITY HEALTHCARE DISTRIBUTION | UNITED STATES | $95.5K | 6 |
| MINT PHARMACEUTICALS INC . | CANADA | $95.4K | 4 |
| TO THE ORDER OF C/O EVERSANA LIFE | UNITED STATES | $82.8K | 9 |
| TO THE ORDER | UNITED STATES | $81.7K | 4 |
| TO THE ORDER OF--- | CANADA | $55.8K | 2 |
| TO THE ORDER OF` | CANADA | $44.1K | 3 |
Hetero Labs Limited supplies Simvastatin to 15 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by MINT PHARMACEUTICALS INC. (CANADA) and TO THE ORDER OF.... (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Simvastatin Export Value and How Much Does Hetero Labs Limited Contribute?
India exported $80.8M worth of Simvastatin through 3,854 shipments from 150 suppliers to 84 countries, serving 421 buyers globally. Hetero Labs Limited contributes $7.1M to this total, accounting for 5.6% of India's Simvastatin exports. Hetero Labs Limited ships Simvastatin to 3 countries through 15 buyers.
What Is the Average Shipment Value for Hetero Labs Limited's Simvastatin Exports?
Hetero Labs Limited's average Simvastatin shipment value is $49.2K per consignment, based on 144 shipments totaling $7.1M. The largest destination is UNITED STATES (85.6% of Hetero Labs Limited's Simvastatin exports).
How Does Hetero Labs Limited Compare to Other Indian Simvastatin Exporters?
Hetero Labs Limited ranks #6 among 150 Indian Simvastatin exporters with a 5.6% market share. The top 3 exporters are LUPIN LIMITED ($20.8M), MYLAN LABORATORIES LIMITED ($13.3M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.4M). Hetero Labs Limited processed 144 shipments to 3 destination countries.
What Simvastatin Formulations Does Hetero Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SIMVASTATIN 40MG TABS (6217x1000's PACK) | $600.0K | 12 |
| SIMVASTATIN 20MG TABS (7862x1000's PACK) | $600.0K | 12 |
| SIMVASTATIN 20MG TABS (3352x1000's PACK) | $583.2K | 12 |
| SIMVASTATIN 10MG TABS (2418x1000's PACK) | $333.7K | 12 |
| SIMVASTATIN TABLET | $269.8K | 9 |
| SIMVASTATIN TABLET 100`S | $120.6K | 5 |
| SIMVASTATIN 20MG TABLET | $100.0K | 2 |
| SIMVASTATIN 40MG TABLET | $100.0K | 2 |
| SIMVASTATIN 20MG TABLET 1000S BATCH NOS:E233381,E233497 NDC NO8200901410TBS | $74.1K | 3 |
| SIMVASTATIN TABLET 100`S | $61.3K | 2 |
Hetero Labs Limited exports 68 distinct Simvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SIMVASTATIN 40MG TABS (6217x1000's PACK) with 12 shipments worth $600.0K.
Regulatory Requirements: Exporting Simvastatin to Key Markets
What Hetero Labs Limited must comply with to export Simvastatin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Hetero Labs Limited Compare to Nearest Simvastatin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.4M | 516 | 5 | $20.1K |
| 5 | AUROBINDO PHARMA LTD | $8.5M | 540 | 7 | $15.8K |
| 6 | HETERO LABS LIMITED ★ | $7.1M | 144 | 3 | $49.2K |
| 3 | IPCA LABORATORIES LIMITED | $3.9M | 77 | 6 | $50.0K |
| 7 | AUROBINDO PHARMA LIMITED | $3.3M | 180 | 8 | $18.4K |
Hetero Labs Limited ranks #6 among 150 Indian Simvastatin exporters. Average shipment value of $49.2K compared to the market average of $538.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Simvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 422 | 10.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 7.8% |
| SAHAR AIR | 240 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 228 | 5.9% |
| DELHI AIR | 216 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 202 | 5.2% |
| VIZAG SEA | 177 | 4.6% |
| MUNDRA SEA | 150 | 3.9% |
What Other Cardiovascular Products Does Hetero Labs Limited Export?
Hetero Labs Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Hetero Labs Limited's Simvastatin Exports
The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.
Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.
The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.
Hetero Labs Limited — Regulatory Compliance & Quality Standards
Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.
About Hetero Labs Limited
Hetero Labs Limited exports 46 products worth $319.3M. Beyond Simvastatin, top products include Tenofovir, Dolutegravir, Ritonavir, Acyclovir, Valacyclovir. View the complete Hetero Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Simvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 144 individual customs records matching Hetero Labs Limited exporting Simvastatin, covering 68 formulations to 3 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 84+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Simvastatin Export Data from Hetero Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Hetero Labs Limited's Simvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Hetero Labs Limited
Full Company Profile →
46 products · $319.3M total trade · 18 categories
Simvastatin Stats
Company Overview
Top Products by Hetero Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Hetero Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Simvastatin. For current shipment-level data, contact TransData Nexus.